Skip to main content
Google Tag Manager
P&T COMMUNITY
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
About
News
P&T Journal
You are here
Home
News by month %2 2014
News by month November 2014
PTCommunity News November 2014
Genentech Defends Supply Shift for Top Cancer Drugs
CDC Report: Only 30% of Americans With HIV Have Virus in Check
FDA Postpones Review of Multiple Myeloma Compound Panobinostat
Psoriasis Treatment Brodalumab Shows Promise in Pivotal Study
New Device May Ease Mammography Discomfort
FDA Approves Onexton Gel for Treatment of Acne Vulgaris
Report: Tecfidera Becoming Key Player on MS Scene
Task Force Finds Insufficient Evidence on Screening for Vitamin D Deficiency in Adults
Powdered Measles Vaccine Found Safe in Early Trial
FDA Warns Against Using Laparoscopic Power Morcellators to Treat Uterine Fibroids
FDA Grants ‘Breakthrough Therapy’ Designation to T-Cell Treatment for Leukemia
Amgen Terminates All Clinical Studies of Rilotumumab in Advanced Gastric Cancer
Scientists Develop Noninvasive Test for Endometriosis
Positive Pivotal Trial Data Reported for Patiromer FOS in Treatment of Hyperkalemia
Experts Dispute Claims of Looming Doctor Shortage
New Device Reduces Scarring in Damaged Blood Vessels
Nanoparticle RSV Vaccine Wins ‘Fast Track’ Designation
Report: Economic Burden of Diabetes Up 48% Over 5 Years
FDA Approves Abuse-Deterrent Hydrocodone Pill
With New Study, Personalized Cancer Vaccines Edge Closer to Reality
Costly Hepatitis C Treatments Help Drive 12% Drug Spending Jump
Dupilumab Receives ‘Breakthrough Therapy’ Designation for Atopic Dermatitis
Encouraging Results Reported for Ovarian Cancer Drug Rucaparib
Report: First Class of Biosimilars to Enter U.S. Market Could Generate $1.8 Billion in Sales by 2023
Daily Hydroxyurea Therapy Safe and Effective in Children With Sickle Cell Anemia, Authors Say
Alirocumab Reduces LDL Cholesterol in Six Phase III Trials
New Drug Application Submitted to FDA for 3-Month Paliperidone Palmitate (Invega Sustenna) for Schizophrenia
Study: Common Blood Pressure Drugs Do Not Increase Risk of Breast Cancer
Oral Apremilast (Otezla) Shows Sustained Clinical Response in Patients With Active Psoriatic Arthritis
FDA Puts Partial Hold on Clinical Trials of Cancer Drug Aldoxorubicin
Report: U.S. Radiology Departments Prepare for Ebola
Portable Electrical Device Slows Growth of Deadliest Brain Cancer
New Fibromyalgia Treatment Shows Promise in Mid-Stage Study
Two Drugs Are No More Effective Than One to Treat Common Kidney Disease
Gallup Poll: Ebola Ranks Among Americans’ Top Three Health Care Concerns
Sierra Leone Doctor Dies of Ebola at Nebraska Hospital
FDA Approves Bevacizumab (Avastin) Plus Chemotherapy for Type of Ovarian Cancer
Blood Test Could Prevent Medication Trial and Error for RA Patients, Mayo Clinic Says
Secukinumab Shows Symptom Improvement in Pivotal Arthritis Studies
MS Treatment Alemtuzumab (Lemtrada) Gets FDA Green Light
FDA Approves Once-Monthly Invega Sustenna (Paliperidone Palmitate) for Schizoaffective Disorder
AstraZeneca Developing Reversal Agent for Its Own Heart Drug, Brilinta (Ticagrelor)
Genetic Testing Could Improve Breast Cancer Prevention, Authors Say
New ‘Guiding Principles’ for Diabetes Care
Survey: Ulcerative Colitis Drug Market Will Grow Over Next Decade
Brodalumab Superior to Ustekinumab (Stelara) in Pivotal Psoriasis Study
Medical Centers Ask Congress to Probe Change in Distribution of Key Cancer Drugs
Study: Baby Boomers Will Drive Explosion in Alzheimer’s-Related Costs in Coming Decades
Researchers Studying Blood Test That Could Reduce Antibiotic Use
Ebola Preparedness Training Available Online
Asthma Patients to Docs: Can We Talk About Cost?
Opioid Overdoses Responsible for About 136,000 Emergency Visits in 2010
Studies Show Beta-Blockers Have No Mortality Benefit in Post-Heart Attack Patients
Dartmouth Report: Lung Cancer Screening With Low-Dose CT Could Be Cost-Effective
FDA Accepts Application for LDL Cholesterol-Lowering Drug Evolocumab
CDC Report: U.S. Skin Cancer Costs Rise in 2002–2011
Hepatitis C Triple Combo Scores Big in Phase III Trials
FDA Panel Says ‘No’ to Multiple Myeloma Compound Panobinostat
In Surprise Move, Supreme Court Will Examine Key Part of Affordable Care Act
FDA Blasts Company for Sleep Drug Ad
Drug for Nonalcoholic Steatohepatitis Shows Promising Results
Bio-Filtration Device Helps Eradicate Virus in Ebola Patient
New Drug Application Submitted to FDA for Single-Tablet HIV Regimen
U.S. Specialists Applaud Harvoni, First Single-Tablet Regimen for HCV Infections
Report: Pneumonia Vaccine Reduces Pediatric Admissions
Hospital Medical Errors Reduced 30% With Improved Patient Handoffs
Simeprevir/Sofosbuvir Combo Gets FDA Nod as All-Oral Treatment for Hepatitis C Infection
FDA Rejects Growth Hormone Test
WHO Issues Update on Ebola Crisis
Ramucirumab/Paclitaxel Combo Approved for Gastric Cancer
FDA Advisors Question Study Data Submitted for Dialysis Therapy
Scientists Develop New Way to Kill Bacteria
Cystic Fibrosis Combo Lumacaftor/Ivacaftor Submitted for FDA Review
Positive Results Reported From Mid-Stage Trial of Cabozantinib (Cometriq) and Erlotinib (Tarceva) in Lung Cancer Patients
Ovarian Cancer Drug Trebananib Fails to Improve Overall Survival
Nine Out of 10 Obese Adults Lose Weight With Liraglutide in Phase III Trial
Survey: Diabetic Nephropathy Considered Renal Disease With Greatest Unmet Need for New Treatments
Aripiprazole Superior to Paliperidone Palmitate in Improving Quality of Life for Schizophrenia Patients
First Guidelines on Use of Complementary Therapies for Breast Cancer
Report: Undiagnosed Chagas Disease Emerging as U.S. Public Health Threat
Report: Nasal Spray Vaccine May Offer Long-Lasting Protection From Ebola Virus
FDA Expands Labeling for Fluzone High-Dose Vaccine for Adults 65 and Older
New Findings Support Safety and Efficacy of Dabigatran (Pradaxa) for Atrial Fibrillation
Promising Mid-Stage Data Reported for HIV Drug Doravirine
FDA Removes Full Clinical Hold on Imetelstat
Increase in Cardiotoxicity Reported in National Surgical Adjuvant Breast and Bowel Project Study
Study Finds Cyclophosphamide Effective in Treating Scleroderma
